Clinical Trial Update: Phase 2a Clinical Trial of HL237 for Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2a clinical trial update for HL237 in rheumatoid arthritis; the status is unknown from the provided snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• HL237

Snippet

Sponsor: Hanlim Pharm. Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: UNKNOWN